Subjects with nummular eczema research hub

An investigator-initiated, multi-center, randomized, double-blind, placebo controlled study of Dupilumab to demonstrate efficacy in subjects with nummular eczema

This study is looking into a new treatment called Dupilumab (Dupixent) for people with a type of eczema called nummular eczema. Researchers want to see if it makes their skin better and improves their quality of life. It's an important step in finding new ways to help manage this skin condition.